Disulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential
Open Access
- 1 December 2017
- journal article
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 7 (3) , 425-432
Abstract
No abstract availableKeywords
Funding Information
- Instituto Nacional de Pediatria (024/2016)
This publication has 35 references indexed in Scilit:
- Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational OptionCurrent Topics in Medicinal Chemistry, 2016
- Structural Effects of Protein Aging: Terminal Marking by Deamidation in Human Triosephosphate IsomerasePLOS ONE, 2015
- Giardial Triosephosphate Isomerase as Possible Target of the Cytotoxic Effect of Omeprazole in Giardia lambliaAntimicrobial Agents and Chemotherapy, 2014
- Treatment of Giardiasis: Current Status and Future DirectionsCurrent Infectious Disease Reports, 2014
- The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessmentThe Lancet Global Health, 2013
- Drug repurposing from an academic perspectiveDrug Discovery Today: Therapeutic Strategies, 2011
- The old and new therapeutic approaches to the treatment of giardiasis: Where are we?2009
- Species-specific inhibition of Giardia lamblia triosephosphate isomerase by localized perturbation of the homodimerMolecular and Biochemical Parasitology, 2008
- Current Trends in Research into the Waterborne Parasite GiardiaCritical Reviews in Microbiology, 2002
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970